Solubility: May be dissolved in DMSO (50 mg/ml); or Ethanol (25 mg/ml, warm)
Appearance: Yellow powder
PubChem CID: 24826799
Scientific Background: Ponatinib is a multi-targeted tyrosine kinase inhibitor. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs).
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.